TL;DR — Key Takeaways
If you’re sitting CIMA SCS May 2026 Strategic Case Study in May or August 2026, you’ve already read the Kwirtmak pre-seen probably more than once. You know the company makes commercial 3D printers. You know there are four factories and four printing technologies. You can recite the board structure.
But here’s the uncomfortable truth: knowing the pre-seen isn’t the same as understanding it. And SCS doesn’t reward recall — it rewards the candidates who can look at a real, messy business situation, work out what’s actually broken, and put forward a clear, defensible recommendation.
The Kwirtmak pre-seen contains seven strategic issues that are likely to drive the questions you’ll see on exam day. In this post, we’re walking through the three biggest ones — the issues you cannot afford to miss. We’ve also embedded the full video below, where our SCS tutor Neesha takes you through them in detail.
A common mistake at this stage of CIMA SCS exam preparation is to keep grinding through E3, P3 and F3 theory in the final weeks. That’s not where the marks are.
SCS assumes you have the technical foundation. What it actually tests is your ability to apply that foundation to a specific company in a specific situation — and Kwirtmak’s situation has some very specific problems. Identifying them in advance gives you a head start the moment you walk into the exam.
Spotting these issues isn’t optional. It’s the difference between a generic, framework-led answer and one that demonstrates you understand this business — which is exactly what examiners reward at strategic level.
Kwirtmak’s revenue fell by 18.8% year-on-year. Its closest competitor, Breskko, grew over the same period. Both companies operate in the same industry, are headquartered in the same country, and have similar global footprints. So why the gap?
Kwirtmak vs. Breskko — At a Glance
Kwirtmak
Revenue change
−18.8%
FX loss FY26
E$44.3m
Position
Vulnerable to takeover
Breskko
Revenue change
Growth
FX loss FY26
~25% of Kwirtmak's
Position
Strengthening
This is the headline strategic problem of the entire pre-seen, and it’s almost certainly going to drive at least one major exam task.
The numbers behind the divergence are even more telling. Revenue dropped by 18.8%, but cost of goods sold only fell by 9.3% — a clear sign of a high fixed cost structure. That means Kwirtmak’s profit erodes faster than its revenue, which puts pressure on margins, return on capital employed (ROCE), and interest cover.
The board needs to identify the cause of the divergence. Four possibilities are worth considering:
This isn’t just a financial issue. It exposes a strategic governance failure: the board hasn’t publicly explained the divergence, which raises questions about non-executive director effectiveness and whether the company is still aligned with its stated vision of being “a leading provider of additive manufacturing solutions.”
Expect exam tasks that ask you to evaluate the cause of the divergence, recommend strategic responses, or comment on board accountability.
Two strategic growth options are heavily flagged in the Kwirtmak pre-seen: developing carbon fibre printing capability, and entering the medical market.
These aren’t accidental. They’re the natural response to Issue 1 — and the examiner will almost certainly want you to evaluate them.
Mapped against the Ansoff matrix, carbon fibre is product development (a new product into existing markets like aerospace and automotive), while medical market entry is market development (existing products into a new market). Both carry different risk profiles and require different evaluation criteria.
Apply the SAF framework to either:
The board also faces a build-buy-partner decision. Should Kwirtmak develop carbon fibre capability organically, acquire a company that already has it, or form a strategic partnership? Each route has different cost, speed, and risk implications — and you should be ready to weigh them.
For the medical market specifically, expect to assess product liability risk, regulatory compliance (which varies wildly across jurisdictions), and reputational risk. Want to dig deeper into all seven pre-seen issues? Our SCS packages include the full video series with Neesha — link is
Likely exam tasks: SAF evaluation, build-buy-partner recommendations, or comparison of which option best closes the gap with Breskko.
E$44.3m
Foreign Exchange Loss in FY26
That's four times higher than Breskko's equivalent loss — despite both companies operating from the same head office country with similar global footprints. A clear signal that hedging policy needs urgent review.
Both companies operate from the same head office country. Both trade globally. Both have overseas subsidiaries. So a four-fold difference in foreign exchange losses isn’t a market issue — it’s a treasury management issue.
There are three types of currency risk Kwirtmak is exposed to:
The most concerning aspect isn’t the loss itself — it’s that foreign exchange risk isn’t disclosed in the company’s risk register. For a material, principle-level risk to be omitted is a clear corporate governance failure, and one the examiner could easily turn into a task on its own.
CFO Agata Paluch — only one year into the role — now needs to lead a comprehensive review of hedging policy, identify which subsidiaries are protected and at what rates, and decide whether to accept customer requests to invoice in their local currency.
Likely exam tasks: recommend appropriate hedging strategies, evaluate current hedging policy, or advise on whether to accept currency-specific customer terms.
Identifying these issues is step one. Step two is making them work for you on exam day.
When you tackle your mock exams — particularly the later ones in your prep cycle — actively map each task back to one of the seven pre-seen issues. Ask yourself: which issue is this task testing? Which other issues could plausibly hook into the same scenario, in line with the CIMA SCS exam structure and pass criteria?
That habit transforms your answers from generic framework recital into something genuinely strategic. It’s also what separates pass-mark candidates from those scoring well into the high marks.
If you’re not yet using a structured set of mock exams that mirror the real CIMA SCS format, our SCS practice tests cover all four levels of preparation — link is
The Kwirtmak pre-seen rewards close reading — not memorisation. The three issues we’ve covered here (revenue divergence, strategic growth options, and foreign exchange risk) are the spine of your CIMA SCS May 2026 exam, and understanding them properly will fundamentally change how you respond to whatever the examiner throws at you on the day.
The other four issues — corporate governance, capital structure, risk register gaps, and acquisitions and ethics — are equally important. Make sure you’ve identified them too, because in SCS, what you spot in advance is what you can win on.
Frequently Asked Questions
What is the Kwirtmak pre-seen for CIMA SCS May 2026?
Kwirtmak Group is the fictional company set as the pre-seen for the May–August 2026 CIMA Strategic Case Study sitting. It's a quoted commercial 3D printer manufacturer operating across aerospace, automotive, jewellery, medical, and consumer electronics sectors. The pre-seen contains the strategic context candidates need to know before sitting the exam.
How many key issues are in the Kwirtmak pre-seen?
Our SCS tutor Neesha has identified seven key issues in the Kwirtmak pre-seen most likely to drive exam questions. They cover revenue divergence, strategic growth options, foreign exchange risk, corporate governance, capital structure, risk register gaps, and acquisitions and ethics.
What is Kwirtmak's biggest strategic problem?
The most pressing issue is the revenue divergence between Kwirtmak and its closest competitor Breskko. Kwirtmak's revenue fell 18.8% year-on-year while Breskko grew, despite operating in the same industry, country, and global markets. This raises serious questions about strategy, governance, and competitive positioning.
Why is Kwirtmak's foreign exchange loss so important?
Kwirtmak lost E$44.3 million on currency in financial year 2026 — four times higher than Breskko's equivalent loss. Both companies have similar overseas operations, so the gap points to weak hedging policy and treasury management. It also exposes a governance failure: foreign exchange risk isn't disclosed in the risk register.
How should I prepare for the CIMA SCS May 2026 exam?
Focus on understanding the pre-seen rather than memorising it. Map the key issues to potential exam scenarios, practise applying frameworks like SAF and Ansoff to Kwirtmak specifically, and complete structured mock exams that mirror the real exam format. Technical revision matters less at this stage than strategic application.
Get Exam-Ready for CIMA SCS May 2026
Mock exams, model answers, pre-seen analysis videos, and tutor feedback — everything you need to walk into your SCS sitting with confidence. Choose the package that matches where you are in your preparation.
Explore SCS Packages → Sign up for our weekly newsletter to receive expert guidance, study resources, career tips, the latest discounts, and more.
Grab your FREE SCS study and practice materials now and boost your chances of passing the Strategic Case Study!
Choose your path to success today!
